Loading page

WholenessCommunity

Shop Learn Community Resources

Find a Provider Sell on WholenessLog in

Preparing your space

WholenessCommunity

A dedicated home where people navigating acute and chronic medical conditions find community, independent providers, and genuine support throughout their journey.

Support hours: Mon–Fri, 9:00 AM – 5:00 PM EST

Join the Community

Explore

Shop
Learn
Community
Resources

Providers

Find a Provider
Sell on Wholeness
Provider Onboarding

Support

Returns & Refunds
About Us
Contact Us
Case Studies

Join our wellness community

Weekly inspiration, provider spotlights and healing resources.

© 2026 WCM LLC, d/b/a Wholeness Community Marketplace. All rights reserved.

Privacy Policy Member Terms Provider Terms Returns & Refunds

Conditions & Recovery · NY Times Health · August 26, 2026

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

Originally published by NY Times Health. We curate and add context; they did the reporting.

Read the full story at NY Times Health ↗

Related learning

Biotech Firm Claims Some Credit for Groundbreaking Virus Research Biotech Firm Claims Some Credit for Groundbreaking Virus Research James P. Allison, Ph.D., bangs gong after completing proton therapy treatment Combination therapy helps plasmacytoid bladder cancer survivor